From Our Partners
Sunday, June 26, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biosecurity

NAMRU-3, Stanford Work to Combat Acute Febrile Illness

by Global Biodefense Staff
August 24, 2015
NAMRU-3 U.S. Naval Medical Research Unit

The Naval Medical Research Center (NMRC) has announced intentions to award a contract to Stanford University to support biosurveillance and biosecurity activities in Liberia.

The effort specifically focuses on known and novel etiologies of Acute Febrile Illness in rural Liberia. Stanford will perform a range of biosurveillance-oriented activities under the effort, including:

  • Training, management and supervision of in-country joint Liberian National and Naval Medical Research Unit Three (NAMRU-3) teams
  • Collection of primary data for epidemiological analysis of the incidence of Acute Febrile Illness
  • Analysis of data and development of population-based estimates on disease occurrence
  • Generation of status reports and final analysis products for publication
  • Liaison activities with local hospital staff at the Kolahun Regional Hospital and the Liberian Institute for Biomedical Research
  • Integration of Kolahun Regional Hospital into the Acute Febrile Illness project
  • Assist with preparation and submission of an Institutional Review Board protocol
  • Define a catchment Area of the population served by the Foya Hospital and disseminated community clinics in Lofa County, Liberia

NAMRU-3 is a U.S. Department of Defense biomedical research laboratory based in Cairo, Egypt. The organization has been working to increase biosurveillance systems and biosecurity across Africa and the Middle East since 1942. NAMRU-3 works closely with the Egyptian Ministry of Health, the U.S. National Institutes of Health, the World Health Organization (WHO), the U.S. Agency for International Development, and the U.S. Centers for Disease Control and Prevention on evaluation of vaccines, therapeutic agents, diagnostic assays, and vector control measures for the region.

The NAMRU-3 mission includes public health activities and capacity building in cooperation with host countries in the region, and the organization was named as a WHO Collaborating Center for Emerging and Re-Emerging Infectious Diseases in 2001. NAMRU-3 also serves as a WHO reference laboratory for influenza and meningitis in the Eastern Mediterranean Region.

From Our Partners
Tags: Awards

Related Posts

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies
Biosurveillance

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
Dual Use Research of Concern: NIH to Host Stakeholder Engagement Meeting on Oversight Policies
Biosecurity

Dual Use Research of Concern: NIH to Host Stakeholder Engagement Meeting on Oversight Policies

June 14, 2022
The Bioethics and Biosecurity Aspects of Targeted Wastewater Surveillance
Biosurveillance

The Bioethics and Biosecurity Aspects of Targeted Wastewater Surveillance

June 9, 2022
BARDA and JPEO-CBRND Back Cepheid’s Multiplex Test for Influenza, SARS-CoV2 and RSV
Health Security

Resurgent COVID-19, Flu and Other Viruses are Pushing New Zealand’s Health System to the Limit

June 2, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC